Quantification and characterization of mucosa-associated and intracellular escherichia coli in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 19, Issue 11, 2013, Pages 2326-2338

  Elliott, Timothy R ^a,b,c   Hudspith, Barry N ^a   Wu, Guanghui ^d   Cooley, Michael ^e   Parkes, Gareth ^a,b   Quiñones, Beatriz ^e   Randall, Luke ^d   Mandrell, Robert E ^e   Fagerquist, Clifton K ^e   Brostoff, Jonathan ^a   Rayment, Neil B ^a   Boussioutas, Alex ^c   Petrovska, Liljana ^d   Sanderson, Jeremy D ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d VETERINARY LABORATORIES AGENCY   (United Kingdom)

^e WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

Adherent invasive E. coli; Crohn's disease; Escherichia coli; Ulcerative colitis

Indexed keywords

GENTAMICIN; VIRULENCE FACTOR;

ADULT; ANTIBIOTIC RESISTANCE GENE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ESCHERICHIA COLI; FEMALE; GENE; HUMAN; HUMAN TISSUE; INFANT; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PATHOGENICITY; PHYLOGENY; PRIORITY JOURNAL; PROTEOMICS; STOMACH BIOPSY; TISSUE CULTURE; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL ADHESION; BIOLOGICAL MARKERS; CACO-2 CELLS; CASE-CONTROL STUDIES; CELLS, CULTURED; COLITIS, ULCERATIVE; CROHN DISEASE; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROGNOSIS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84888234793     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e3182a38a92     Document Type: Article

References (59)

1. Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 2010;16:90-97.
2. Smith AM, Rahman FZ, Hayee B, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohns disease. J Exp Med. 2009;206:1883-1897.
3. Heazlewood CK, Cook MC, Eri R, et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 2008;5:e54.
4. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell. 2008;134:743-756.
5. Wehkamp J, Harder J, Weichenthal M, et al. NOD2 (CARD15) mutations in Crohns disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004;53:1658-1664.
6. Van Klinken BJ, Van der Wal JW, Einerhand AW, et al. Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut. 1999;44:387-393.
7. De Cruz P, Prideaux L, Wagner J, et al. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:372-390.
8. Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohns disease. Inflamm Bowel Dis. 2009;15:653-660.
9. Mondot S, Kang S, Furet JP, et al. Highlighting new phylogenetic specificities of Crohns disease microbiota. Inflamm Bowel Dis. 2011;17: 185-192.
10. Fujita H, Eishi Y, Ishige I, et al. Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases. J Gastroenterol. 2002;37:509-516.
11. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44-54.
12. Mylonaki M, Rayment NB, Rampton DS, et al. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:481-487.
13. Baumgart M, Dogan B, Rishniw M, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohns disease involving the ileum. ISME J. 2007;1:403-418.
14. Rehman A, Lepage P, Nolte A, et al. Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J Med Microbiol. 2010;59:1114-1122.
15. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, et al. Abnormal microbiota composition in the ileocolonic mucosa of Crohns disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis. 2006;12:1136-1145.
16. Martinez-Medina M, Aldeguer X, Lopez-Siles M, et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohns disease. Inflamm Bowel Dis. 2009;15:872-882.
17. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohns disease of the colon. Gut. 2003;52:237-242.
18. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohns disease and colon cancer. Gastroenterology. 2004;127:80-93.
19. Cartun RW, Van Kruiningen HJ, Pedersen CA, et al. An immunocytochemical search for infectious agents in Crohns disease. Mod Pathol. 1993;6:212-219.
20. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol. 2002;37:1034-1041.
21. Liu Y, van Kruiningen HJ, West AB, et al. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohns disease. Gastroenterology. 1995;108:1396-1404.
22. Ryan P, Kelly RG, Lee G, et al. Bacterial DNA within granulomas of patients with Crohns disease-detection by laser capture microdissection and PCR. Am J Gastroenterol. 2004;99:1539-1543.
23. Schultsz C, Van Den Berg FM, Ten Kate FW, et al. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology. 1999;117:1089-1097.
24. Walmsley RS, Anthony A, Sim R, et al. Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. J Clin Pathol. 1998;51: 657-661.
25. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohns disease. Gastroenterology. 2004;127:412-421.
26. Schultsz C, Moussa M, van Ketel R, et al. Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J Clin Pathol. 1997;50:573-579.
27. Sepehri S, Kotlowski R, Bernstein CN, et al. Phylogenetic analysis of inflammatory bowel disease associated Escherichia coli and the fimH virulence determinant. Inflamm Bowel Dis. 2009;15:1737-1745.
28. Subramanian S, Roberts CL, Hart CA, et al. Replication of colonic Crohns disease mucosal Escherichia coli isolates within macrophages and their susceptibility to antibiotics. Antimicrob Agents Chemother. 2008;52:427-434.
29. Daperno M, DHaens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohns disease: the SES-CD. Gastrointest Endosc. 2004;60:505-512.
30. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J. 1964;1: 89-92.
31. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000; 66:4555-4558.
32. Quiñones B, Swimley M, Narm K, et al. O-antigen and virulence profiling of shiga toxin-producing Escherichia coli by a rapid and cost-effective DNA microarray colorimetric method. Front Cell Infect Microbiol. 2012;2:61.
33. Kyle JL, Cummings CA, Parker CT, et al. Escherichia coli serotype O55: H7 diversity supports parallel acquisition of bacteriophage at Shiga toxin phage insertion sites during evolution of the O157:H7 lineage. J Bacteriol. 2012;194:1885-1896.
34. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis. 2000;181:261-272.
35. Batchelor M, Hopkins KL, Liebana E, et al. Development of a miniaturised microarray-based assay for the rapid identification of antimicrobial resistance genes in Gram-negative bacteria. Int J Antimicrob Agents. 2008;31:440-451.
36. Geue L, Schares S, Mintel B, et al. Rapid microarray-based genotyping of enterohemorrhagic Escherichia coli serotype O156:H25/H-/Hnt isolates from cattle and clonal relationship analysis. Appl Environ Microbiol. 2010;76:5510-5519.
37. Png CW, Linden SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105:2420-2428.
38. Vaudaux P,Waldvogel FA. Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1979;16:743-749.
39. Swidsinski A, Khilkin M, Kerjaschki D, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology. 1998; 115:281-286.
40. Cookson ST, Nataro JP. Characterization of HEp-2 cell projection formation induced by diffusely adherent Escherichia coli. Microb Pathog. 1996; 21:421-434.
41. Rayment N, Mylonaki M, Hudspith B, et al. Co-localisation of E. coli with macrophages in lamina propria in patients with active inflammatory bowel, disease (IBD). Gut. 2003;52:A13.
42. Aluwihare AP. Electron microscopy in Crohns disease. Gut. 1971;12: 509-518.
43. Thyberg J, Graf W, Klingenstrom P. Intestinal fine structure in Crohns disease. Lysosomal inclusions in epithelial cells and macrophages. Virchows Arch A Pathol Anat Histol. 1981;391:141-152.
44. Zeissig S, Burgel N, Gunzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohns disease. Gut. 2007;56:61-72.
45. Flanagan PK, Campbell BJ, Rhodes J. Hydroxychloroquine as a treatment for Crohns disease: enhancing antibiotic efficacy and macrophage killing of E coli. Gut. 2012;61:A60-A61.
46. Martinez-Medina M, Mora A, Blanco M, et al. Similarity and divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli strains. J Clin Microbiol. 2009;47:3968-3979.
47. Simpson KW, Dogan B, Rishniw M, et al. Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun. 2006;74:4778-4792.
48. Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol. 2008;85:11-19.
49. Bingen E, Picard B, Brahimi N, et al. Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J Infect Dis. 1998;177:642-650.
50. Geyid A, Fletcher J, Gashe BA, et al. Invasion of tissue culture cells by diarrhoeagenic strains of Escherichia coli which lack the enteroinvasive inv gene. FEMS Immunol Med Microbiol. 1996;14:15-24.
51. Sasaki M, Sitaraman SV, Babbin BA, et al. Invasive Escherichia coli are a feature of Crohns disease. Lab Invest. 2007;87:1042-1054.
52. Dobrindt U, Blum-Oehler G, Hartsch T, et al. S-fimbria-encoding determinant sfa(I) is located on pathogenicity island III(536) of uropathogenic Escherichia coli strain Infect Immun. 2001;69:4248-4256.
53. Lu S, Zhang X, Zhu Y, et al. Complete genome sequence of the neonatalmeningitis-associated Escherichia coli strain CE10. J Bacteriol. 2011; 193:7005.
54. Tobe T, Beatson SA, Taniguchi H, et al. An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A. 2006;103:14941-14946.
55. Kotlowski R, Bernstein CN, Sepehri S, et al. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut. 2007;56:669-675.
56. Tenaillon O, Skurnik D, Picard B, et al. The population genetics of commensal Escherichia coli. Nat Rev Microbiol. 2010;8:207-217.
57. Pitout JD. Extraintestinal pathogenic Escherichia coli: A combination of virulence with antibiotic resistance. Front Microbiol. 2012;3:9.
58. Bailey JK, Pinyon JL, Anantham S, et al. Commensal Escherichia coli of healthy humans: A reservoir for antibiotic-resistance determinants. J Med Microbiol. 2010;59:1331-1339.
59. Fagerquist CK, Garbus BR, Miller WG, et al. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics. Anal Chem. 2010;82:2717-2725.